Skip to main content
Premium Trial:

Request an Annual Quote

MDx Firm QuantuMDx Buys NorthGene

NEW YORK (GenomeWeb News) – Molecular diagnostics firm QuantuMDx said today it has bought identity testing company NorthGene in a stock and cash deal for an undisclosed amount.

Founded in 1995 as a spin-out of Newcastle University in the UK, NorthGene provides paternity and other relationship testing. QuantuMDx said that it plans to build out NorthGene's laboratory and staffing infrastructure, secure laboratory accreditation, and expand its test portfolio and DNA analysis services "to embrace medical, veterinary, and scientific research application."

NorthGene has been run as a not-for-profit with all revenues invested into medical research. QuantuMDx CEO Elaine Warburton said in a statement that her firm will continue "this philanthropic philosophy of using NorthGene surpluses to invest in advancing medical research for the benefit of global health."

Additionally, QuantuMDx will "play a key role in the testing and the commercial roll-out of our ground-breaking diagnostic and sequencing devices, which are now close to market," she added.

QuantumDx, also based in Newcastle, has a license from Nanosys to use nanowire field effect transistor biosensors for biomarker detection and sequencing applications.

The technology was developed in the laboratory of Harvard University chemistry professor Charles Lieber, a Nanosys co-founder. Target-specific nucleotides can be bound to an array of the nanowires to detect PCR-amplified target nucleic acids. The nanowires can sense these binding events and instantly convert them into electronic signals.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.